HEPION PHARMACEUTICALS, INC. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2022-11-08: .
- 2021-09-30: .
- 2021-06-30: .
- 2021-03-31: .
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock Dividends, Income Statement Impact | Preferred Stock, Accretion of Redemption Discount | Preferred Stock Convertible Conversion Price |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | $1.00 10-K · filed 2024-04-16 | ||||||
| 2021-09-30 | $5.82K 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | $5.29K 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | $5.29K 10-Q · filed 2021-05-14 | ||||||
| 2020-12-31 | $5.29K 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | $5.29K 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | ||||||
| 2019-12-31 | $4.67M 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | $4.67M 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | $4.67M 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | $24.32K 10-Q · filed 2020-06-29 | ||||||
| 2015-06-30 | $7.84M 10-K · filed 2016-09-28 | ||||||
| 2015-03-31 | $3.00M 10-Q · filed 2016-05-13 | ||||||
| 2014-12-31 | $4.84M 10-Q · filed 2016-02-12 | ||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | 20.00M shares 10-Q · filed 2014-11-13 | 0.00 shares 10-Q · filed 2014-11-13 | 0.00 shares 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | $0.00 10-Q · filed 2014-11-13 | 20.00M shares 10-Q · filed 2014-11-13 | 0.00 shares 10-Q · filed 2014-11-13 | 0.00 shares 10-Q · filed 2014-11-13 | |||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | 20.00M shares 10-Q · filed 2014-05-15 | 0.00 shares 10-Q · filed 2014-05-15 | 0.00 shares 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-05 | 20.00M shares 10-Q · filed 2014-02-05 | 0.00 shares 10-Q · filed 2014-02-05 | 0.00 shares 10-Q · filed 2014-02-05 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | 20.00M shares 10-Q · filed 2013-11-19 | 0.00 shares 10-Q · filed 2013-11-19 | 0.00 shares 10-Q · filed 2013-11-19 | |||
| 2013-06-30 | $0.00 10-K · filed 2014-09-29 | 20.00M shares 10-K · filed 2014-09-29 | 0.00 shares 10-K · filed 2014-09-29 | 0.00 shares 10-K · filed 2014-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |